These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 21880584)

  • 1. Best alternative to vancomycin for serious methicillin-resistant Staphylococcus aureus infections: let's just say it.
    Bush LM
    Clin Infect Dis; 2011 Nov; 53(9):965-6. PubMed ID: 21880584
    [No Abstract]   [Full Text] [Related]  

  • 2. [Persistent bacteremia due to methicillin-resistant Staphylococcus aureus. A result of inadequate treatment].
    Parra-Ruiz J; Tomas-Jiménez C; Muñoz-Medina L; Hernández-Quero J
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):372-3. PubMed ID: 19339080
    [No Abstract]   [Full Text] [Related]  

  • 3. Vancomycin minimum inhibitory concentrations and outcome in patients with severe Staphylococcus aureus infection.
    Gould IM
    J Infect Dis; 2012 Mar; 205(5):864-5; author reply 865-6. PubMed ID: 22238463
    [No Abstract]   [Full Text] [Related]  

  • 4. Association Between Vancomycin Trough Concentrations and Duration of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children.
    Hsu AJ; Hamdy RF; Huang Y; Olson JA; Ghobrial S; Gerber JS; Hersh AL; Tamma PD
    J Pediatric Infect Dis Soc; 2018 Dec; 7(4):338-341. PubMed ID: 28992126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Neuner EA; Casabar E; Reichley R; McKinnon PS
    Diagn Microbiol Infect Dis; 2010 Jul; 67(3):228-33. PubMed ID: 20542203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The detection and clinical impact of vancomycin MIC among patients with methicillin-resistant Staphylococcus aureus bacteremia.
    Huang CH; Chen YH
    J Microbiol Immunol Infect; 2013 Aug; 46(4):315-6. PubMed ID: 23623179
    [No Abstract]   [Full Text] [Related]  

  • 7. Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK.
    Lewis T; Chaudhry R; Nightingale P; Lambert P; Das I
    Int J Infect Dis; 2011 Feb; 15(2):e131-5. PubMed ID: 21134776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is high vancomycin minimum inhibitory concentration a good marker to predict the outcome of methicillin-resistant Staphylococcus aureus bacteremia?
    Lalueza A; Chaves F; San Juan R; Daskalaki M; Otero JR; Aguado JM
    J Infect Dis; 2010 Jan; 201(2):311-2; author reply 312-3. PubMed ID: 20034343
    [No Abstract]   [Full Text] [Related]  

  • 9. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.
    Holubar M; Meng L; Alegria W; Deresinski S
    Infect Dis Clin North Am; 2020 Dec; 34(4):849-861. PubMed ID: 33011050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Audit of the management of Staphylococcus aureus bloodstream infection: gaps to be plugged.
    Barry A; McNicholas S; Smyth E; Humphreys H; Fitzpatrick F
    J Hosp Infect; 2010 Nov; 76(3):272-3. PubMed ID: 20435374
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on the global number of vancomycin-resistant Staphylococcus aureus (VRSA) strains.
    Moravvej Z; Estaji F; Askari E; Solhjou K; Naderi Nasab M; Saadat S
    Int J Antimicrob Agents; 2013 Oct; 42(4):370-1. PubMed ID: 23880172
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of pharmacodynamic target attainment with vancomycin treatment of bacteremia due to Staphylococcus aureus methicillin resistant].
    Lepe JA; Gil-Navarro MV; Santos-Rubio MD; Bautista J; Aznar J
    Rev Esp Quimioter; 2010 Mar; 23(1):43-7. PubMed ID: 20232023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of vancomycin serum trough concentrations and outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
    Arshad S; Shoyinka A; Chen A; Jacobsen G; Zervos M
    Int J Antimicrob Agents; 2012 Nov; 40(5):474-5. PubMed ID: 22883416
    [No Abstract]   [Full Text] [Related]  

  • 14. Fatal bacteraemia caused by daptomycin-non-susceptible, vancomycin-intermediate, meticillin-resistant Staphylococcus aureus in a patient with chronic kidney disease.
    Kuo CC; Wu VC; Huang YT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2009 Jan; 33(1):96-8. PubMed ID: 18790610
    [No Abstract]   [Full Text] [Related]  

  • 15. Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia.
    Barber KE; Rybak MJ; Sakoulas G
    J Antimicrob Chemother; 2015 Jan; 70(1):311-3. PubMed ID: 25125677
    [No Abstract]   [Full Text] [Related]  

  • 16. Vancomycin susceptibility of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia isolates from two UK hospitals over a decade.
    Karas JA; Enoch DA; Fish D; Foweraker JE
    Int J Antimicrob Agents; 2010 Aug; 36(2):189-90. PubMed ID: 20451354
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimicrobial salvage therapy for native valve MRSA endocarditis.
    Cortes J; Sagar AS; Lee Y; Sandhu U; Boka K
    J Antimicrob Chemother; 2017 Jun; 72(6):1841-1842. PubMed ID: 28333236
    [No Abstract]   [Full Text] [Related]  

  • 18. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.
    Murray KP; Zhao JJ; Davis SL; Kullar R; Kaye KS; Lephart P; Rybak MJ
    Clin Infect Dis; 2013 Jun; 56(11):1562-9. PubMed ID: 23449272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing levels of minimum inhibitory concentration vancomycin in methicillin resistant Staphylococcus aureus alarming bell for vancomycin abusers?
    Veer P; Chande C; Chavan S; Wabale V; Chopdekar K; Bade J; Joshi A
    Indian J Med Microbiol; 2010; 28(4):413-4. PubMed ID: 20966589
    [No Abstract]   [Full Text] [Related]  

  • 20. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
    Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S
    J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.